A new JAK inhibitor drug may help reduce the risk of graft versus host disease in half-matched stem cell transplants, according to a new study.
A phase I trial of the investigational drug, itacitinib, has had unexpectedly promising results, accord...
3 months ago
A monoclonal antibody has shown promise as an effective new treatment for haemophilia, German researchers have reported.
The antibody normalises thrombin formation, leading the developers to hope it will reduce long-term complications from the dis...
3 months ago
